Kyiv: American biotechnology company Novavax announced the start of testing its new type of vaccine against Coronavirus COVID-19, ABC News reports.
The first stage of clinical research will take part people from 18 to 59 years old who have not previously had “Coronavirus”.
It should be added that the results of the first phase of testing will be known in July 2020. If the drug successfully passes all stages of research, then at least 100 million doses will be able to produce it this year, and next year - 1.5 billion.
Earlier, according to the publication, the drug Novavax has successfully passed animal tests. In the course of studies, it became known that the effect of the vaccine is more effective against COVID-19 with the introduction of small doses.
As previously reported, Washington announced the possible intentions of the PRC to steal the development of a vaccine against Coronavirus from the United States.